ketamine has been researched along with Female Genitourinary Diseases in 3 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chu, PS | 1 |
Cheung, RY | 1 |
Chan, SS | 1 |
Lee, JH | 1 |
Pang, AW | 1 |
Choy, KW | 1 |
Chung, TK | 1 |
Wei, YB | 1 |
Yang, JR | 1 |
3 other studies available for ketamine and Female Genitourinary Diseases
Article | Year |
---|---|
Persistence of urinary symptoms after cessation of ketamine abuse.
Topics: Excitatory Amino Acid Antagonists; Female; Female Urogenital Diseases; Humans; Ketamine; Quality of | 2011 |
Urinary symptoms and impaired quality of life in female ketamine users: persistence after cessation of use.
Topics: Body Mass Index; Excitatory Amino Acid Antagonists; Female; Female Urogenital Diseases; Humans; Keta | 2011 |
Moxifloxacin relieves the persistent symptoms of lower urinary tract after cessation of ketamine abuse.
Topics: Excitatory Amino Acid Antagonists; Female; Female Urogenital Diseases; Humans; Ketamine; Quality of | 2011 |